Surgery Partners, Inc.
SGRY
$13.97
$0.191.38%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 3.34B | 3.31B | 3.29B | 3.24B | 3.17B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 3.34B | 3.31B | 3.29B | 3.24B | 3.17B |
| Cost of Revenue | 2.58B | 2.54B | 2.50B | 2.47B | 2.42B |
| Gross Profit | 763.30M | 765.00M | 786.40M | 768.60M | 752.20M |
| SG&A Expenses | 121.50M | 118.20M | 130.50M | 137.30M | 141.50M |
| Depreciation & Amortization | 178.20M | 176.00M | 150.00M | 160.70M | 155.20M |
| Other Operating Expenses | -10.40M | -8.70M | -13.10M | -13.60M | -18.00M |
| Total Operating Expenses | 2.87B | 2.83B | 2.77B | 2.75B | 2.70B |
| Operating Income | 474.00M | 479.50M | 519.00M | 484.20M | 473.50M |
| Income Before Tax | 113.90M | 116.90M | 148.50M | 128.60M | 118.10M |
| Income Tax Expenses | 16.80M | 18.00M | 125.20M | 124.20M | 130.20M |
| Earnings from Continuing Operations | 97.10 | 98.90 | 23.30 | 4.40 | -12.10 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -173.20M | -176.80M | -194.70M | -184.80M | -181.30M |
| Net Income | -76.10M | -77.90M | -171.40M | -180.40M | -193.40M |
| EBIT | 474.00M | 479.50M | 519.00M | 484.20M | 473.50M |
| EBITDA | 652.20M | 655.50M | 669.00M | 644.90M | 628.70M |
| EPS Basic | -0.60 | -0.61 | -1.36 | -1.43 | -1.53 |
| Normalized Basic EPS | -0.30 | -0.26 | -0.13 | -0.10 | -0.05 |
| EPS Diluted | -0.60 | -0.62 | -1.36 | -1.43 | -1.53 |
| Normalized Diluted EPS | -0.30 | -0.26 | -0.13 | -0.10 | -0.05 |
| Average Basic Shares Outstanding | 510.58M | 508.82M | 507.00M | 505.96M | 505.12M |
| Average Diluted Shares Outstanding | 510.58M | 508.82M | 507.00M | 505.96M | 505.12M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |